Literature DB >> 15709020

Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception.

Alec J Redwood1, Martin Messerle, Nicole L Harvey, Christopher M Hardy, Ulrich H Koszinowski, Malcolm A Lawson, Geoffrey R Shellam.   

Abstract

Cytomegaloviruses (CMVs) are members of the Betaherpesvirinae subfamily of the Herpesviridae, and their properties of latency, large DNA size, gene redundancy, and ability to be cloned as bacterial artificial chromosomes (BACs) suggest their utility as vaccine vectors. While the K181 strain of murine CMV (MCMV) is widely used to study MCMV biology, a BAC clone of this virus had not previously been produced. We report here the construction of a BAC clone of the K181(Perth) strain of MCMV. The in vivo and in vitro growth characteristics of virus derived from the K181 BAC were similar to those of wild-type K181. The utility of the K181 BAC as a method for the rapid production of vaccine vectors was assessed. A vaccine strain of BAC virus, expressing the self-fertility antigen, murine zona pellucida 3, was produced rapidly using standard bacterial genetics techniques and rendered female BALB/c mice infertile with a single intraperitoneal inoculation. In addition, attenuated vaccine strains lacking the open reading frames m07 to m12 exhibited no reduction in efficacy compared to the full-length vaccine strain. In conclusion, we describe the production of a K181-based BAC virus which behaved essentially as wild-type K181 and allowed the rapid production of effective viral vaccine vectors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709020      PMCID: PMC548423          DOI: 10.1128/JVI.79.5.2998-3008.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Analysis in vitro of two biologically distinct strains of murine cytomegalovirus.

Authors:  J B Hudson; D G Walker; M Altamirano
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

3.  New and versatile cloning vectors with kanamycin-resistance marker.

Authors:  R D Pridmore
Journal:  Gene       Date:  1987       Impact factor: 3.688

4.  Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth.

Authors:  W C Manning; E S Mocarski
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

5.  Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells.

Authors:  Valentina Voigt; Catherine A Forbes; Joanne N Tonkin; Mariapia A Degli-Esposti; Hamish R C Smith; Wayne M Yokoyama; Anthony A Scalzo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

6.  Minor base sequence differences between the genomes of two strains of murine cytomegalovirus differing in virulence.

Authors:  V Misra; J B Hudson
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

7.  Molecular cloning and physical mapping of murine cytomegalovirus DNA.

Authors:  A Ebeling; G M Keil; E Knust; U H Koszinowski
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

8.  Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith Strain).

Authors:  J A Mercer; J R Marks; D H Spector
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

9.  Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes.

Authors:  Xiuqing Wang; Martin Messerle; Ramil Sapinoro; Kathlyn Santos; Peter K Hocknell; Xia Jin; Stephen Dewhurst
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen.

Authors:  A A Scalzo; N A Fitzgerald; A Simmons; A B La Vista; G R Shellam
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  41 in total

1.  Electrochemical detection of a single cytomegalovirus at an ultramicroelectrode and its antibody anchoring.

Authors:  Jeffrey E Dick; Adam T Hilterbrand; Aliaksei Boika; Jason W Upton; Allen J Bard
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

2.  Functional Dissection of an Alternatively Spliced Herpesvirus Gene by Splice Site Mutagenesis.

Authors:  Tim Schommartz; Stefan Loroch; Malik Alawi; Adam Grundhoff; Albert Sickmann; Wolfram Brune
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

3.  The mouse cytomegalovirus glycoprotein m155 inhibits CD40 expression and restricts CD4 T cell responses.

Authors:  Andrea I Loewendorf; Lars Steinbrueck; Christoph Peter; Andreas Busche; Chris A Benedict; Penelope C Kay-Jackson
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

Review 4.  Cytomegalovirus antivirals and development of improved animal models.

Authors:  Alistair McGregor; K Yeon Choi
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-09-01       Impact factor: 4.481

5.  Methods for Studying the Function of Cytomegalovirus GPCRs.

Authors:  Christine M O'Connor; William E Miller
Journal:  Methods Mol Biol       Date:  2021

6.  Knockout of the Host Resistance Gene Pkr Fully Restores Replication of Murine Cytomegalovirus m142 and m143 Mutants In Vivo.

Authors:  Eleonore Ostermann; Gabriele Warnecke; Zoe Waibler; Wolfram Brune
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

7.  Remarkably Robust Antiviral Immune Response despite Combined Deficiency in Caspase-8 and RIPK3.

Authors:  Yanjun Feng; Devon Livingston-Rosanoff; Linda Roback; Aarthi Sundararajan; Samuel H Speck; Edward S Mocarski; Lisa P Daley-Bauer
Journal:  J Immunol       Date:  2018-09-07       Impact factor: 5.422

8.  A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose.

Authors:  Yoshimi Tsuda; Christopher J Parkins; Patrizia Caposio; Friederike Feldmann; Sara Botto; Susan Ball; Ilhem Messaoudi; Luka Cicin-Sain; Heinz Feldmann; Michael A Jarvis
Journal:  Vaccine       Date:  2015-03-25       Impact factor: 3.641

9.  Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis.

Authors:  Lynsey N Crosby; A Louise McCormick; Edward S Mocarski
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

10.  Activation of intracellular signaling pathways by the murine cytomegalovirus G protein-coupled receptor M33 occurs via PLC-{beta}/PKC-dependent and -independent mechanisms.

Authors:  Joseph D Sherrill; Melissa P Stropes; Olivia D Schneider; Diana E Koch; Fabiola M Bittencourt; Jeanette L C Miller; William E Miller
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.